Trial Profile
Short Term Effects of Leptin Withdrawal or Initiation in Lipodystrophy Independent of Energy Intake
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metreleptin (Primary)
- Indications Lipodystrophy
- Focus Pharmacodynamics
- 23 Apr 2021 Primary endpoint has been met. (Total Body Insulin Sensitivity in initiation and Withdrawal cohort), as per Results published in the Journal of Clinical Endocrinology and Metabolism
- 23 Apr 2021 Primary endpoint has been met. (total energy expenditure in Withdrawal cohort), as per Results published in the Journal of Clinical Endocrinology and Metabolism
- 23 Apr 2021 Primary endpoint has been met. (total energy expenditure in initiation cohort), as per Results published in the Journal of Clinical Endocrinology and Metabolism